What is the ATXS stock price prediction for next 2 weeks?

According to our price prediction algorithm,Astria Therapeutics, Inc. (ATXS) price will be around $12.07 in the next 2 weeks. This means it will decrease by -4.026232114467415 from the last closing price. This prediction may vary from other time period filters for ATXS stock.

What can be the highest Possible price of ATXS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ATXS can achieve the highest price of $12.24 which is -2.722796422510874 lower than last closing price. This prediction may vary from other time period filters for ATXS stock.

What can be the lowest Possible price of ATXS stock in next 2 weeks?

As per the forecast and algorithmic analysis, ATXS stock price can be as low as $11.92 which is -5.232977217554496 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for ATXS stock.

Will ATXS stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that ATXS stock will lose-4.026232114467415 in the next 2 weeks. This prediction may vary from other time period filters for ATXS stock.

What is ATXS stock last closing price?

Last closing price of ATXS stock was $12.58.

What is ATXS stock price prediction?

ATXS stock price prediction means predicting the future closing prices of ATXS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ATXS stock in a certain time period.

How we predict ATXS stock future prices?

If you are searching for ATXS stock forecast, analysis or price prediction, then you might be wondering what Astria Therapeutics, Inc. (ATXS) will do in the future. Our ATXS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ATXS price prediction will likely answer most of your questions.

How frequent we update ATXS stock predictions?

We are updating the forecasts for the ATXS stock on daily basis.

Is using ML forecasting for ATXS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ATXS stock same for all the time periods?

No, the prediction for ATXS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Astria Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$12.580%Since 2 Weeks

Predicted Price$12.07-4.03%For 2 Weeks

Upper Predicted Price$12.24-2.72%For 2 Weeks

Lower Predicted Price$11.92-5.23%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ATXS will decline by -4.03% over the next 2 Weeks and hit $12.07 by Thursday, February 5, 2026. In that time frame, ATXS's share price is expected to range between $11.92 and $12.24.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 5, 2026	11.89	12.05	12.20
Feb 4, 2026	11.83	11.98	12.14
Feb 3, 2026	11.76	11.91	12.07
Feb 2, 2026	11.81	11.97	12.11
Jan 30, 2026	11.93	12.08	12.24
Jan 29, 2026	12.15	12.29	12.44
Jan 28, 2026	12.08	12.23	12.37
Jan 27, 2026	12.00	12.15	12.30
Jan 26, 2026	12.07	12.21	12.35
Jan 23, 2026	12.18	12.33	12.47

ATXS shares remained flat 0 in Friday, January 23, 2026's trading session, starting and closing at a previous close of $12.58 to move at $12.58. The stock demonstrated notable intraday movement (see ATXS's key stats for a full breakdown), fluctuating between $12.58 and $12.58, a 0 trading range. While recent weeks have seen some volatility, ATXS has managed to secure a -3.08% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 3.15M shares changing hands, 2.21M more than the previous session. This amounted to $39.67M in total market activity.

Will ATXS Continue Its Downward Trend?

According to analyst ratings and projections for ATXS, Astria Therapeutics, Inc. shares are anticipated to decrease by -3.08%, potentially reaching $12.20 per share by February 5, 2026. Short-term technical indicators currently suggest a neutral sentiment for ATXS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the ATXS stock forecast, now is not the best time to buy ATXS stock because its current trading price is +4.44% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ATXS covering social and institutional perspectives.

ATXS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ATXS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 44.11% to 49.91%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 58.96%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 57.65%, maintains a neutral outlook for the long term. Insights into ATXS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Astria Therapeutics Short-Term Forecasts

ATXS Forecast For Next 5 Days

Our algorithm anticipates Astria Therapeutics (ATXS) stock could hit $12.93 by Feb 13, 2026. This represents a +2.81% fall from today's price, following a -2.20% change over the past five days.

ATXS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Astria Therapeutics, Inc. (ATXS) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $12.90, which would mean a +2.54% increase from the current price of $12.58. Projections for this period range from a high of $13.35 to a low of $12.51.

ATXS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Astria Therapeutics's price over the next three months point to a rise. ATXS stock is expected to peak at $34.02 on Mar 20, 2026 before potentially dipping to $22.22 on May 20, 2026. On average, ATXS is likely to trade around $26.92 in the coming 90 days.

Astria Therapeutics Stock Forecast 2025

Based on our predictive models, Astria Therapeutics (ATXS) is expected to trade between $20.74 and $66.05 throughout 2026. This would result in an average price of $33.19, potentially offering investors a +163.83% return from current levels.

Astria Therapeutics, Inc. Monthly Forecast 2026–2027

February 2026

According to our latest forecast models, Astria Therapeutics, Inc. (ATXS) is positioned to show a strong performance in February 2026. The price is predicted to move between $29.07 and $31.06, settling at an average of $30.10. This could translate to a +139.27% gain.

March 2026

Based on current market signals, Astria Therapeutics, Inc. is projected to trend march 2026. We forecast a trading range from $28.50 to $34.02, with a likely average price of $30.94. Investors could expect a potential return of +145.95%.

April 2026

Our predictive algorithms indicate Astria Therapeutics, Inc. stock may see a shift in April 2026. The expected range spans $25.04–$29.81, with an average target of $26.76. This represents a positive outlook and a possible gain of +112.72%.

May 2026

Analyzing established trends, Astria Therapeutics, Inc. looks set to move in May 2026. Projections place the stock between $22.22 and $28.21, averaging around $24.40. This suggests a +93.96% gain from current levels.

June 2026

Market indicators suggest Astria Therapeutics, Inc. could experience notable changes during June 2026. Prices could fluctuate within $20.74 to $27.67, with a midpoint forecast of $23.75. The stock might deliver a +88.79% gain.

July 2026

Forecasting for July 2026, models estimate that Astria Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $20.79 and $36.65, averaging $27.69. This signals a positive trajectory with potential returns around +120.11%.

August 2026

According to our latest forecast models, Astria Therapeutics, Inc. (ATXS) is positioned to show a strong performance in August 2026. The price is predicted to move between $30.22 and $45.06, settling at an average of $33.80. This could translate to a +168.68% gain.

September 2026

Based on current market signals, Astria Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $36.79 to $46.73, with a likely average price of $37.85. Investors could expect a potential return of +200.87%.

October 2026

Our predictive algorithms indicate Astria Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $34.92–$54.48, with an average target of $39.65. This represents a positive outlook and a possible gain of +215.18%.

November 2026

Analyzing established trends, Astria Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $38.87 and $57.98, averaging around $42.28. This suggests a +236.09% gain from current levels.

December 2026

Market indicators suggest Astria Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $39.31 to $66.05, with a midpoint forecast of $46.61. The stock might deliver a +270.51% gain.

January 2027

Forecasting for January 2027, models estimate that Astria Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $47.63 and $66.15, averaging $49.44. This signals a positive trajectory with potential returns around +293.00%.

ATXS's history of dividends and stock splits also plays a role in long-term investor confidence.